FDA Clearance Tracker · K201432
Masimo O3 Regional Oximeter System
Last checked: Nov 19, 2026Latest source record: Aug 29, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Aug 29, 2020
Substantially Equivalent
Time to decision
89 days
Received Jun 1, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K201432
- Device name
- Masimo O3 Regional Oximeter System
- Applicant
- Masimo Corporation
- Applicant location
- Irvine, CA
- Received
- Jun 1, 2020
- Decided
- Aug 29, 2020
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Oximeter, Tissue Saturation (MUD)
- Device class
- Class II
- Regulation
- 21 CFR 870.2700
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MUD. The earliest in FDA's data is K963903, decided Jan 27, 1998.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K201432
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Masimo Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260676 · Decided Oct 14, 2026 · 226 days after receipt
Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX) · Cardiology
K253417 · Decided Aug 12, 2026 · 315 days after receipt
Device type: Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms) (MWI) · Cardiology
- SedLine Sedation Monitor510(k)
K260880 · Decided Jul 10, 2026 · 115 days after receipt
Device type: Index-Generating Electroencephalograph Software (OLW) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.